Scholarlink

Background <p>Esophagectomy with gastric conduit reconstruction is one of the standard treatment for esophageal cancer; however, anastomotic leakage remains a major complication, occurring in approximately 13% of cases. Impaired perfusion of the gastric conduit is a key risk factor, highlighting the need for objective intraoperative blood flow assessment. Although indocyanine green (ICG) fluorescence imaging has been used, quantitative evaluation is lacking, and perfusion of the remnant esophagus has not been assessed. The SPY-QP system provides objective, real-time perfusion analysis using fluorescence intensity metrics. This study examines the role of SPY-QP–guided perfusion assessment in supporting intraoperative anastomotic decision-making and explores its association with a reduced incidence of anastomotic leakage compared with conventional near-infrared evaluation.</p> Methods <p>This investigator-initiated, prospective, single-arm clinical study (SPYMIE study) aims to evaluate the feasibility and effectiveness of quantitative perfusion assessment using the SPY-QP fluorescence system during minimally invasive esophagectomy for esophageal cancer. Intraoperative ICG fluorescence imaging is performed to quantify blood flow in the gastric conduit and remnant esophagus. The primary endpoint is the incidence of anastomotic leakage, with secondary outcomes including anastomotic stricture, gastric conduit necrosis, and relative fluorescence intensity at anastomotic sites. Historical controls with conventional near-infrared evaluation will be used for comparison.</p> Discussion <p>Anastomotic leakage after minimally invasive esophagectomy remains a major concern, largely attributed to inadequate perfusion at the anastomotic site. Conventional intraoperative assessments are subjective and lack quantitative reliability. The SPY-QP system enables real-time, quantitative perfusion analysis, providing measurable parameters such as relative ICG fluorescence intensity and time-to-peak intensity. Prior studies demonstrated that SPY-QP detects low-perfusion regions unseen with qualitative imaging and influences surgical decision-making, leading to reduced leakage rates. Therefore, SPY-QP–guided quantitative perfusion assessment may enhance intraoperative blood flow evaluation of anastomotic sites, standardize perfusion-based surgical quality indicators in esophagectomy.</p> Trial registration <p>This SPYMIE study was prospectively registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN-CTR) on May 12, 2025 (registration number: UMIN000057825) under the title <i>“Prospective</i>,<i> single-arm study on the usefulness of blood flow evaluation of the gastric conduit and remnant esophagus using the SPY-QP software system in minimally invasive esophagectomy for esophageal cancer.”</i></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

SPY-QP–guided perfusion assessment to prevent esophagogastric anastomotic leakage: protocol for the SPYMIE study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月29日

查看全文
  • Tomoaki Aoki,
  • Hironobu Goto,
  • Yasufumi Koterazawa,
  • Masayuki Ando,
  • Yutaka Sugita,
  • Taro Ikeda,
  • Hitoshi Harada,
  • Yasunori Otowa,
  • Naoki Urakawa,
  • Hiroshi Hasegawa,
  • Shingo Kanaji,
  • Kimihiro Yamashita,
  • Takeru Matsuda,
  • Yoshihiro Kakeji

摘要

Background

Esophagectomy with gastric conduit reconstruction is one of the standard treatment for esophageal cancer; however, anastomotic leakage remains a major complication, occurring in approximately 13% of cases. Impaired perfusion of the gastric conduit is a key risk factor, highlighting the need for objective intraoperative blood flow assessment. Although indocyanine green (ICG) fluorescence imaging has been used, quantitative evaluation is lacking, and perfusion of the remnant esophagus has not been assessed. The SPY-QP system provides objective, real-time perfusion analysis using fluorescence intensity metrics. This study examines the role of SPY-QP–guided perfusion assessment in supporting intraoperative anastomotic decision-making and explores its association with a reduced incidence of anastomotic leakage compared with conventional near-infrared evaluation.

Methods

This investigator-initiated, prospective, single-arm clinical study (SPYMIE study) aims to evaluate the feasibility and effectiveness of quantitative perfusion assessment using the SPY-QP fluorescence system during minimally invasive esophagectomy for esophageal cancer. Intraoperative ICG fluorescence imaging is performed to quantify blood flow in the gastric conduit and remnant esophagus. The primary endpoint is the incidence of anastomotic leakage, with secondary outcomes including anastomotic stricture, gastric conduit necrosis, and relative fluorescence intensity at anastomotic sites. Historical controls with conventional near-infrared evaluation will be used for comparison.

Discussion

Anastomotic leakage after minimally invasive esophagectomy remains a major concern, largely attributed to inadequate perfusion at the anastomotic site. Conventional intraoperative assessments are subjective and lack quantitative reliability. The SPY-QP system enables real-time, quantitative perfusion analysis, providing measurable parameters such as relative ICG fluorescence intensity and time-to-peak intensity. Prior studies demonstrated that SPY-QP detects low-perfusion regions unseen with qualitative imaging and influences surgical decision-making, leading to reduced leakage rates. Therefore, SPY-QP–guided quantitative perfusion assessment may enhance intraoperative blood flow evaluation of anastomotic sites, standardize perfusion-based surgical quality indicators in esophagectomy.

Trial registration

This SPYMIE study was prospectively registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN-CTR) on May 12, 2025 (registration number: UMIN000057825) under the title “Prospective, single-arm study on the usefulness of blood flow evaluation of the gastric conduit and remnant esophagus using the SPY-QP software system in minimally invasive esophagectomy for esophageal cancer.”